Gregg Vicky B 4

What Happened

• Vicky B. Gregg, a director of Quest Diagnostics (DGX), was awarded 1,142 restricted stock units (RSUs) on May 20, 2026. The Form 4 reports the acquisition as 1,142 shares at $0.00 per share (award/grant), with an acquisition value reported as $0. This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-20; reported on Form 4 filed 2026-05-21 (timely filing).
• Transaction type/code: A — Award/Grant (restricted stock units).
• Shares acquired: 1,142 RSUs at $0.00 per share (award).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: F1 states these are restricted stock units (RSUs).
• No indication of a 10b5-1 plan, tax withholding, or immediate sale in the filing.

Context

• RSU awards are common for directors as compensation and are typically subject to vesting and other conditions; they do not necessarily represent an immediate market purchase or sale.
• Because this is a grant of RSUs (not a purchase), it should be viewed as compensation-related rather than a direct bullish or bearish signal by the insider.